28-Mar-2024
TipRanks (Tue, 26-Mar 7:15 AM ET)
Business Wire (Thu, 7-Mar 4:01 PM ET)
Arcturus Therapeutics to Present at the Barclays 26th Annual Global Healthcare Conference
Business Wire (Mon, 26-Feb 9:00 AM ET)
Business Wire (Thu, 22-Feb 8:30 AM ET)
Business Wire (Tue, 20-Feb 9:00 AM ET)
Business Wire (Mon, 5-Feb 8:30 AM ET)
PRNewswire (Fri, 5-Jan 1:17 PM ET)
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.
Arcturus Therapeutics Holdings trades on the NASDAQ stock market under the symbol ARCT.
As of March 28, 2024, ARCT stock price climbed to $33.77 with 508,310 million shares trading.
ARCT has a beta of 3.09, meaning it tends to be more sensitive to market movements. ARCT has a correlation of 0.23 to the broad based SPY ETF.
ARCT has a market cap of $908.93 million. This is considered a Small Cap stock.
Last quarter Arcturus Therapeutics Holdings reported $34 million in Revenue and -$.32 earnings per share. This fell short of revenue expectation by $-4 million and exceeded earnings estimates by $.67.
In the last 3 years, ARCT stock traded as high as $65.00 and as low as $11.70.
The top ETF exchange traded funds that ARCT belongs to (by Net Assets): ARKG, XBI, VTI, IWM, VXF.
ARCT has outperformed the market in the last year with a return of +113.1%, while the SPY ETF gained +33.6%. However, in the most recent history, ARCT shares have underperformed the stock market with its stock returning +3.1% in the last 3 month period and -10.9% for the last 2 week period, while SPY has returned +10.1% and +1.7%, respectively.
ARCT support price is $31.26 and resistance is $34.46 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ARCT stock will trade within this expected range on the day.